CYH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Community Health Systems Inc (CYH) is not a strong buy for a beginner, long-term investor at this time. The company's financial performance is weak, with declining revenue, net income, and EPS. Analysts have mixed views, with a lowered price target from Wells Fargo and a modest increase from Truist. Technical indicators show a neutral to slightly positive trend, but no strong upward momentum. Options data reflects low put-call ratios, indicating a bullish sentiment, but this is not enough to offset the weak fundamentals and lack of significant positive catalysts. For a long-term investor, it would be prudent to wait for stronger financial performance or clearer positive signals before considering this stock.
The MACD is positive and expanding, suggesting mild bullish momentum. RSI is neutral at 77.259, and moving averages are converging, indicating no strong directional trend. The stock is trading near its R1 resistance level of 3.45, with potential upside to R2 at 3.576. However, the stock's next-day and next-week probabilities suggest minor declines, with a 6.48% chance of gain over the next month.
Options data indicates a bullish sentiment with low put-call ratios. Technical indicators show mild bullish momentum with MACD expanding positively.
Weak financial performance in Q3 2025, with revenue, net income, and EPS all declining significantly YoY. Analysts have mixed ratings, with Wells Fargo lowering the price target and maintaining an Underweight rating. No recent news or significant trading trends from hedge funds or insiders. No recent congress trading data.
In Q3 2025, revenue dropped by -0.10% YoY to $3.087 billion. Net income fell drastically by -133.25% YoY to $130 million, and EPS declined by -132.54% YoY to 0.96. Gross margin increased slightly by 0.69% YoY to 81.6%. Overall, financial performance is weak.
Analysts have mixed views. Wells Fargo lowered the price target to $2 from $3 and maintained an Underweight rating, citing a challenging environment for hospitals. Truist raised the price target to $4.50 from $4 and maintained a Hold rating, citing solid demand trends and capital deployment efforts in the hospital sector.
